Status:
COMPLETED
HDAC Activity in Peripheral Skeletal Muscle in COPD
Lead Sponsor:
Imperial College London
Conditions:
COPD
Eligibility:
All Genders
40-85 years
Brief Summary
We wish to study the effect of Chronic Obstructive Pulmonary Disease on the activity of the nuclear transcription pathway in peripheral skeletal muscle to determine whether altered activity of this pa...
Detailed Description
Peripheral muscle dysfunction is well recognised in COPD. We wish to study patients who we have found to have weak quadriceps muscles and study the molecular mechanisms underlying this problem. Patien...
Eligibility Criteria
Inclusion
- COPD
- \-
Exclusion
- Aspirin therapy Bleeding diasthesis Neuromuscular disease
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00180752
Start Date
September 1 2005
End Date
August 1 2008
Last Update
February 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton Hospital
London, London, United Kingdom, SW3 6NP